Literature DB >> 25248837

Decreased expression of organic cation transporters, Oct1 and Oct2, in brain microvessels and its implication to MPTP-induced dopaminergic toxicity in aged mice.

Kuo-Chen Wu1, Ya-Hsuan Lu1, Yi-Hsuan Peng1, Ting-Fen Tsai2, Yu-Han Kao1, Hui-Ting Yang1, Chun-Jung Lin1.   

Abstract

This study was to investigate the influence of age on the expression of organic cation transporters (OCTs) that belong to the SLC22 family in brain microvessels (BMVs) and its implications for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic toxicity in mice. Here, we showed that Oct1 and Oct2, but not Oct3, mRNAs were detected and enriched (compared with cerebral cortex) in BMVs of C57BL/6 (B6) mice using reverse transcription-quantitative PCR (RT-qPCR), and immunofluorescence analysis further revealed that Oct1 and Oct2 proteins were colocalized with endothelial markers. Both the mRNA and protein levels of Oct1 and Oct2 were reduced in aged mice. After an intraperitoneal administration of MPTP, brain extracellular levels of MPTP and 1-methyl-4-phenyl-pyridinium (MPP(+)) were much lower in aged mice and in Oct1/2(-/-) mice compared with younger mice and wild-type control mice, respectively. Knockout of Oct1/Oct2 protected Oct1/2(-/-) mice from MPTP-induced neurotoxicity, whereas the loss of tyrosine hydroxylase (TH)-positive neurons was slightly greater in aged than in younger mice. However, intrastriatal infusion of low-dose MPTP caused more severe dopaminergic toxicity in the substantia nigra of both aged mice and Oct1/2(-/-) mice. These findings show that age-dependent downregulation or knockout of Oct1/Oct2 in BMVs may reduce the transport of MPTP, which, in part, affects its dopaminergic toxicity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25248837      PMCID: PMC4294392          DOI: 10.1038/jcbfm.2014.162

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  37 in total

1.  Increase in salsolinol level in the cerebrospinal fluid of parkinsonian patients is related to dementia: advantage of a new high-performance liquid chromatography methodology.

Authors:  L Antkiewicz-Michaluk; A Krygowska-Wajs; A Szczudlik; I Romańska; J Vetulani
Journal:  Biol Psychiatry       Date:  1997-09-15       Impact factor: 13.382

2.  Evidence for generation of oxidative stress in brain by MPTP: in vitro and in vivo studies in mice.

Authors:  K Sriram; K S Pai; M R Boyd; V Ravindranath
Journal:  Brain Res       Date:  1997-02-21       Impact factor: 3.252

3.  Elevation of neuronal MAO-B activity in a transgenic mouse model does not increase sensitivity to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

Authors:  J K Andersen; D M Frim; O Isacson; M F Beal; X O Breakefield
Journal:  Brain Res       Date:  1994-09-05       Impact factor: 3.252

Review 4.  Ageing, neurodegeneration and Parkinson's disease.

Authors:  John V Hindle
Journal:  Age Ageing       Date:  2010-01-05       Impact factor: 10.668

5.  Morphometry of the human substantia nigra in ageing and Parkinson's disease.

Authors:  Gay Rudow; Richard O'Brien; Alena V Savonenko; Susan M Resnick; Alan B Zonderman; Olga Pletnikova; Laura Marsh; Ted M Dawson; Barbara J Crain; Mark J West; Juan C Troncoso
Journal:  Acta Neuropathol       Date:  2008-02-23       Impact factor: 17.088

6.  Change in P-glycoprotein and caveolin protein expression in brain striatum capillaries in New Zealand obese mice with type 2 diabetes.

Authors:  Kuo-Chen Wu; Huei-Ju Pan; Hsiang-Shu Yin; Mei-Ru Chen; Shao-Chun Lu; Chun-Jung Lin
Journal:  Life Sci       Date:  2009-11-03       Impact factor: 5.037

7.  A dopaminergic neurotoxin, (R)-N-methylsalsolinol, increases in Parkinsonian cerebrospinal fluid.

Authors:  W Maruyama; T Abe; H Tohgi; P Dostert; M Naoi
Journal:  Ann Neurol       Date:  1996-07       Impact factor: 10.422

8.  Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone.

Authors:  Takashi Okura; Asami Hattori; Yusuke Takano; Takenori Sato; Margareta Hammarlund-Udenaes; Tetsuya Terasaki; Yoshiharu Deguchi
Journal:  Drug Metab Dispos       Date:  2008-07-07       Impact factor: 3.922

9.  MPTP-induced oxidative stress and neurotoxicity are age-dependent: evidence from measures of reactive oxygen species and striatal dopamine levels.

Authors:  S F Ali; S N David; G D Newport; J L Cadet; W Slikker
Journal:  Synapse       Date:  1994-09       Impact factor: 2.562

10.  The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway.

Authors:  Mei Cui; Radha Aras; Whitney V Christian; Phillip M Rappold; Mamata Hatwar; Joseph Panza; Vernice Jackson-Lewis; Jonathan A Javitch; Nazzareno Ballatori; Serge Przedborski; Kim Tieu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-29       Impact factor: 11.205

View more
  12 in total

1.  P-Glycoprotein Transport of Neurotoxic Pesticides.

Authors:  Sarah E Lacher; Kasse Skagen; Joachim Veit; Rachel Dalton; Erica L Woodahl
Journal:  J Pharmacol Exp Ther       Date:  2015-08-13       Impact factor: 4.030

Review 2.  Solute Carriers in the Blood-Brain Barier: Safety in Abundance.

Authors:  Katarzyna A Nałęcz
Journal:  Neurochem Res       Date:  2016-08-09       Impact factor: 3.996

3.  Regulation of P-glycoprotein expression in brain capillaries in Huntington's disease and its impact on brain availability of antipsychotic agents risperidone and paliperidone.

Authors:  Yu-Han Kao; Yijuang Chern; Hui-Ting Yang; Hui-Mei Chen; Chun-Jung Lin
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-13       Impact factor: 6.200

Review 4.  Metformin and cognition from the perspectives of sex, age, and disease.

Authors:  Kiran Chaudhari; Conner D Reynolds; Shao-Hua Yang
Journal:  Geroscience       Date:  2020-01-02       Impact factor: 7.713

5.  Inhibition by Multifunctional Magnetic Nanoparticles Loaded with Alpha-Synuclein RNAi Plasmid in a Parkinson's Disease Model.

Authors:  Shuiqin Niu; Ling-Kun Zhang; Li Zhang; Siyi Zhuang; Xiuyu Zhan; Wu-Ya Chen; Shiwei Du; Liang Yin; Rong You; Chu-Hua Li; Yan-Qing Guan
Journal:  Theranostics       Date:  2017-01-01       Impact factor: 11.556

6.  Neurotoxin-Induced Animal Models of Parkinson Disease: Pathogenic Mechanism and Assessment.

Authors:  Xian-Si Zeng; Wen-Shuo Geng; Jin-Jing Jia
Journal:  ASN Neuro       Date:  2018 Jan-Dec       Impact factor: 4.146

Review 7.  Genetic polymorphisms of organic cation transporter 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes: A systematic review.

Authors:  Edith Pascale Mofo Mato; Magellan Guewo-Fokeng; M Faadiel Essop; Peter Mark Oroma Owira
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

8.  Molecular imaging identifies age-related attenuation of acetylcholine in retrosplenial cortex in response to acetylcholinesterase inhibition.

Authors:  Theodosia Vallianatou; Mohammadreza Shariatgorji; Anna Nilsson; Elva Fridjonsdottir; Patrik Källback; Nicoletta Schintu; Per Svenningsson; Per E Andrén
Journal:  Neuropsychopharmacology       Date:  2019-04-22       Impact factor: 7.853

9.  Changes of blood-brain-barrier function and transfer of amyloid beta in rats with collagen-induced arthritis.

Authors:  Po-Hsuan Lai; Ting-Hsuan Wang; Nai-You Zhang; Kuo-Chen Wu; Chung-Chen Jane Yao; Chun-Jung Lin
Journal:  J Neuroinflammation       Date:  2021-01-30       Impact factor: 8.322

10.  An Interspecies Molecular and Functional Study of Organic Cation Transporters at the Blood-Brain Barrier: From Rodents to Humans.

Authors:  Catarina Chaves; Federica Campanelli; Hélène Chapy; David Gomez-Zepeda; Fabienne Glacial; Maria Smirnova; Meryam Taghi; Johan Pallud; Nicolas Perrière; Xavier Declèves; Marie-Claude Menet; Salvatore Cisternino
Journal:  Pharmaceutics       Date:  2020-03-28       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.